Abstract
Abstract The difficulty of early diagnosis, high tumor heterogeneity, and high recurrence and metastasis rates lead to an unsatisfactory treatment status for hepatocellular carcinoma (HCC). HCC is a typical inflammation-driven tumor. Chronic inflammation allows nascent tumors to escape immunosurveillance. Chemokines are small, soluble, secreted proteins that can regulate the activation and trafficking of immune cells during inflammation. Several studies have shown that various chemokines with overarching functions disrupt the immune microenvironment during the initiation and progression of HCC. The dysregulated chemokine network in HCC contributes to multiple malignant processes, including angiogenesis, tumor proliferation, migration, invasion, tumor low response, and resistance to immune therapy. Here, we summarize the current studies focusing on the role of chemokines and their receptors in the HCC immune microenvironment, highlighting potential translational therapeutic uses for modulating the chemokine system in HCC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
